Multiple Myeloma Academy

IACH is proud to present the IACH Multiple Myeloma Academy by the international Academy for Clinical Hematology. This is a groundbreaking initiative designed to advance, education, collaboration, and innovation in the field of Multiple Myeloma. As treatment landscapes evolve with cutting edge therapies and novel combinations staying ahead is essential. The IACH Multiple Myeloma Academy will serve as a hub for expert lead discussions, case based learning and the latest clinical advancement, empowering physicians and healthcare professionals worldwide to enhance patient outcomes as we build a global community committed to transforming care in the field.

For any questions please contact – [email protected]

The IACH Multiple Myeloma Academy is supported by an unrestricted educational grant provided by Sanofi.